Trial intelligence / Profile preview

Oral N-acetylcysteine vs placebo for acne severity

IRCT20120215009014N226Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in acne vulgaris comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: Change in acne severity. Started Jul 2018; status: completed.

02

Drugs

acetylcysteine
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on IRCT20120215009014N226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call